Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSD for Cluster Headache
NCT03781128Phase 2Active, not recruiting
- Sponsor
- University Hospital Basel
- Start
- Jan 2019
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lysergide in Cluster Headache (CH) (2 arms), sponsored by University Hospital Basel. Primary endpoints: Change in frequency of the cluster headache attacks at 8 weeks and Change in intensity of the cluster headache attacks at 8 weeks. Started Jan 2019; status: active, not recruiting.
02
Drugs
Lysergide
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT03781128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781128.